From: Methods to discriminate primary from secondary dengue during acute symptomatic infection
 | Performance | |||||
---|---|---|---|---|---|---|
AUC (95% CI) | Accuracy | Sens. | Spec. | PPV | NPV | |
Early-phase models (102 primary vs 135 secondary dengue) | ||||||
 Panbio Indirect IgG | 0.89 (0.84–0.93) | 0.87 | 0.91 | 0.82 | 0.87 | 0.88 |
 In-house anti-E indirect IgG | 0.81 (0.75–0.86) | 0.77 | 0.73 | 0.82 | 0.84 | 0.69 |
 In-house capture IgG | 0.83 (0.77–0.89) | 0.83 | 0.81 | 0.86 | 0.89 | 0.77 |
 In-house capture IgM/IgG ratio | 0.82 (0.76–0.88) | 0.82 | 0.86 | 0.76 | 0.83 | 0.80 |
Late-phase models (98 primary vs 116 secondary dengue) | ||||||
 Panbio Indirect IgG | 0.89 (0.85–0.93) | 0.85 | 0.93 | 0.74 | 0.81 | 0.90 |
 In-house anti-E indirect IgG | 0.73 (0.67–0.80) | 0.71 | 0.82 | 0.59 | 0.70 | 0.73 |
 In-house capture IgG | 0.85 (0.80–0.91) | 0.85 | 0.92 | 0.77 | 0.82 | 0.89 |
 In-house capture IgM/IgG ratio | 0.90 (0.86–0.94) | 0.86 | 0.94 | 0.77 | 0.83 | 0.91 |
Dual-phase models (95 primary vs 109 secondary dengue) | ||||||
 Panbio Indirect IgG | 0.90 (0.86–0.94) | 0.86 | 0.89 | 0.83 | 0.86 | 0.87 |
 In-house anti-E indirect IgG | 0.79 (0.72–0.85) | 0.74 | 0.72 | 0.77 | 0.78 | 0.70 |
 In-house capture IgG | 0.86 (0.81–0.92) | 0.85 | 0.91 | 0.79 | 0.83 | 0.88 |
 In-house capture IgM/IgG ratio | 0.90 (0.86–0.94) | 0.86 | 0.93 | 0.79 | 0.83 | 0.90 |
Days 3–6 models (90 primary vs 102 secondary dengue) | ||||||
 Panbio Indirect IgG | 0.92 (0.88–0.96) | 0.88 | 0.92 | 0.82 | 0.85 | 0.90 |
 In-house anti-E indirect IgG | 0.82 (0.76–0.89) | 0.79 | 0.79 | 0.79 | 0.81 | 0.77 |
 In-house capture IgG | 0.89 (0.84–0.94) | 0.88 | 0.91 | 0.83 | 0.86 | 0.89 |
 In-house capture IgM/IgG ratio | 0.93 (0.89–0.96) | 0.88 | 0.95 | 0.79 | 0.84 | 0.93 |